Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 495/04 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) A61K 31/675 (2006.01) C07D 491/04 (2006.01) C07D 491/048 (2006.01) C07D 498/04 (2006.01) C07D 513/04 (2006.01) C07F 9/6561 (2006.01)

Patent

CA 2180014

Compounds having formula (I) are antagonists of the actions of leukotrienes. These compounds are useful as anti-asthmatic, ant- allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection.

Les composés de formule (I) sont des antagonistes des effets des leucotriènes et sont utilisés comme agents anti-asthmatiques, anti-allergiques, anti-inflammatoires et cytoprotecteurs. Ils sont également utiles pour le traitement de l'angine de poitrine, des spasmes cérébraux, de la glomérulonéphrite, de l'hépatite, de l'endotoxémie, de l'uvéite et du rejet d'allogreffe.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1492182

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.